Uxin Ltd (UXIN) Financial Statements
Uxin Ltd (UXIN) reported trailing twelve-month revenue of $3.2B (up 71.3% year on year) and net income of -$262.5M, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: -$525.8M.
Source: SEC EDGAR filings · read by EquiReason
UXINUxin LtdFollow UXIN — free
—
Price chart with a free account
- Market cap
- 184.1M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 16 Dec, in 53 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters.
| Line | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2021 Mar 21 | FY2022 Mar 22 | FY2023 Mar 23 | FY2024 Mar 24 | FY2025 Dec 25 | TTM | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.31 | 0.66 | 1.59 | 0.66 | 1.64 | 2.06 | 1.37 | 3.24 | — | |
| Gross profit | 0.22 | 0.24 | 0.90 | -0.02 | 0.05 | 0.03 | 0.08 | 0.22 | — | |
| Research & development | — | 0.12 | 0.14 | 0.07 | 0.04 | 0.04 | 0.03 | 0.01 | — | |
| Operating income | -0.39 | -2.49 | -1.29 | -0.55 | -0.28 | -0.36 | -0.31 | -0.17 | — | |
| Pre-tax income | -1.27 | -1.35 | -1.36 | -0.73 | -0.14 | -0.15 | -0.38 | -0.26 | — | |
| Income tax | 0.00 | 0.00 | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | |
| Net income | -2.72 | -1.52 | -1.99 | -0.42 | -0.14 | -0.14 | -0.37 | -0.26 | — | |
| Diluted EPS ($) | — | -0.73 | — | — | -0.33 | -0.66 | -1.11 | 0.00 | — | |
| Diluted shares (bn) | — | 0.478 | 0.887 | 1.331 | 1.355 | 1.345 | 2.185 | 62.756 | — |
USD billions · SEC XBRL
Uxin Ltd — questions
- What is Uxin Ltd's revenue?
- $3.2B over the twelve months to the latest filing, up 71.3% year on year, from its 10-Q and 10-K filings.
- What is Uxin Ltd's net income?
- -$262.5M over the twelve months to .
- What is Uxin Ltd's free cash flow?
- -$525.8M over the twelve months to .
Every figure on this page comes from Uxin Ltd's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.